James E. Flynn - 31 Dec 2024 SCHEDULE 13G/A Report for Catalyst Pharmaceuticals, Inc. Common Stock (CPRX)

Filing Manager
James E. Flynn
Reporting Manager
Deerfield Mgmt, L.P.
Security
Catalyst Pharmaceuticals, Inc. Common Stock
Symbol
CPRX
Shares outstanding
119M shares
Disclosed Ownership
3.13M shares
Ownership
2.63%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2025, 08:57:09 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deerfield Mgmt, L.P. 2.63% 3.13M 0 3.13M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
Deerfield Management Company, L.P. 2.63% 3.13M 0 3.13M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
Deerfield Partners, L.P. 2.63% 3.13M 0 3.13M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
James E. Flynn 2.63% 3.13M 0 3.13M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact